Advertisement

Topics

NEKTAR Company Profile

10:03 EDT 25th June 2018 | BioPortfolio

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapies, and leverage our knowledge and extensive development expertise to evaluate how they can more effectively impact patients’ lives.Just over 15 years ago, our company was founded on breakthrough ideas that changed the way people thought about disease treatment and introduced new and exciting ways to increase the therapeutic value of medicines. Today, we are developing our own high-value, proprietary products as well as highly differentiated products in partnership with leading pharmaceutical and biotechnology companies.

Location

150 Industrial Road
San Carlos
California
94070
United States of America

Contact

Phone: 650.631.3100
Fax: 650.631.3150
Email: NektarSC@nektar.com


News Articles [108 Associated News Articles listed on BioPortfolio]

Nektar Therapeutics Turns Negative After Reaching Record High

WASHINGTON (dpa-AFX) - After initially moving to the upside, shares of Nektar Therapeutics (NKTR) have turned lower over the course of the trading session on Monday. Nektar is currently down by 4....

UPDATE 1-Bristol-Myers to pay $1.85 bln in cancer deal with Nektar

Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion for a global development and profit-sharing deal on a promising Nektar cancer drug, the companies announced on Wednesday. In one of t...

Bristol-Myers to pay $1.85B in cancer deal with Nektar

Nektar will receive $1 billion in cash upfront and Bristol-Myers will purchase about 8.28 million Nektar shares at $102.60 per share, or an equity stake of just under 5 percent of the company

Nektar and Syndax enter trial collaboration for metastatic melanoma

Nektar Therapeutics and Syndax Pharmaceuticals Inc. have paired up to evaluate the combination of Syndax’s entinostat with Nektar’s NKTR214 for metastatic melanoma patients whose disease progresse...

Nektar signs up on record-breaking collaboration deal

Rather surprisingly, US biotech firm Nektar Therapeutics was trading down 4.32% at $72.39 pre-market…

Nektar signs up on record-breaking licensing deal

Rather surprisingly, US biotech firm Nektar Therapeutics was trading down 4.32% at $72.39 pre-market…

Go Big or Go Home: Bristol-Myers Bets $3.6B on Nektar's Early-Stage Cancer Prospect

Rumors of Nektar Therapeutics being up for sale may have been premature.

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

Nektar’s NKTR-214 to be paired with Opdivo and Yervoy in a host of tumour types

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NEKTAR

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapi...

Pearl Therapeutics, Inc.

Pearl Therapeutics is developing a pipeline of advanced respiratory products that will offer patients and their healthcare providers a choice of formulations and dosage strengths better suited to ...

Nektar Therapeutics

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapi...

More Information about "NEKTAR" on BioPortfolio

We have published hundreds of NEKTAR news stories on BioPortfolio along with dozens of NEKTAR Clinical Trials and PubMed Articles about NEKTAR for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NEKTAR Companies in our database. You can also find out about relevant NEKTAR Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record